IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Ventures Fund IV, L.P.

Q1 2016 Holdings

Filed 2016-05-13 | 3 holdings | $381.8K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2016-06-03) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Seres Therapeutics Inc.(MCRB1EUR)COM81750R102$374.1K14,083,57998.0%
T2 Biosystems, Inc.COM89853L104$7.3K741,7551.9%
Eleven Biotherapeutics, Inc.COM286221106$4691,466,4170.1%